Canterbury District Health Board

Institution (Healthcare)

Homepage ROR

Also Known As

Canterbury District Health Board · Acronym: CDHB

1.5K

Publications

51.4K

Citations

131

Authors

638

Concepts

About

Canterbury District Health Board is a healthcare institution in Ashburton, New Zealand known for medicine, public health, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	23	52	1.8K
2	Engineering	15	29	1.3K
3	Education	11	22	645
4	Arts	6	8	207
5	Business	2	3	47

Canterbury District Health Board

1.5K

Publications

51.4K

Citations

Page 1

	Year	Citations
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis Christiane Graetz, John Zajicek Nature Genetics ImmunogeneticsDisease SusceptibilityAutoimmune DiseaseAllergyMedicine	2013	1.4K
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 Melanie Bahlo Nature Genetics Genome-wide Association StudyDisease SusceptibilityChromosomes 12Autoimmune DiseaseGenetics	2009	547
Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand Q. Sue Huang, Tim Wood, Lauren Jelley, Nature Communications	2021	467
Validation of High-Sensitivity Troponin I in a 2-Hour Diagnostic Strategy to Assess 30-Day Outcomes in Emergency Department Patients With Possible Acute Coronary Syndrome Louise Cullen, Christian Mueller, William Parsonage, Journal of the American College of Cardiology High-sensitivity TroponinCardiovascular DiseaseMyocardial InfarctionCoronary Artery DiseaseDiagnosis	2013	314
Low‐fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial Matthew Phillips, Deborah K. J. Murtagh, Linda J. Gilbertson, Movement Disorders	2018	275
Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes Olivia J. Collyns, Renee A. Meier, Zara L. Betts, Diabetes Care Type 1Diabetes ManagementHealth PolicyConclusions AhclInsulin Management	2021	260
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial Georgina V. Long, Victoria Atkinson, Jonathan Cebon, The Lancet Oncology Standard-dose PembrolizumabMedicineMelanomaClinical TrialsImmune Checkpoint Inhibitor	2017	246
Population‐based cases control study of inflammatory bowel disease risk factors Richard B. Gearry, Ann Richardson, Christopher Frampton, Journal of Gastroenterology and Hepatology	2010	235
Interpreting Lung Function Data Using 80% Predicted and Fixed Thresholds Misclassifies More Than 20% of Patients Martin R. Miller, Philip H. Quanjer, Maureen P. Swanney, CHEST Journal Health InformaticsAdvanced Lung DiseaseDiagnosisBiostatisticsPublic Health	2010	223
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia Ian M. Morison, Elisabeth M. Cramer, Emma J. Cheesman, Nature Genetics Malignant Blood DisorderApoptosisHematologyPathologyCell Death	2008	178

Page 1